Birmingham-based ResBiotic has created a drug development spin-off, Alveolus Bio, and launched its first consumer health product, resB Lung Support. Together, the parent firm and spin-off are using $4.5 million in seed funding as they work “to transform the respiratory care landscape and chart new frontiers for microbiome science.” The firms’ work is based on…
ResBiotic creates pharmaceutical subsidiary
Birmingham firm also raises $4.5M in seed funding and launches first consumer health product
